This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Cushing's Syndrome
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

Working hypothesis: the interactions between the endogenous endocannabinoïds (ECS) - and cortisol, the end product of the Hypothalamo-Pituitary-Adrenal (HPA) axis may play a role in the pathophysiology of Cushing's syndrome. The investigators speculate that: - acute or chronic variations in plasma cortisol may induce changes in the activity of the ECS - that there is a circadian rhythm of the ECS driven by the rythm of plasma cortisol

Provided treatments

  • Other: Obese
  • Procedure: Hypercortisolism
  • Other: Hydrocortisone
  • Other: Control

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02889224. The sponsor of the trial is University Hospital, Bordeaux and it is looking for 40 volunteers for the current phase.
Official trial title:
In Vivo Study of Interactions Between the Endocannabinoid System and the Corticotropic Axis in Man